human pluripotent stem cell modulators (Talisman Therapeutics)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namehuman pluripotent stem cell modulators (Talisman Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionStem cells modulatorsCNS modulators
TargetsUpdating
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Cambridge
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTalisman TherapeuticsUniversity Of Cambridge
Active IndicationsN/A
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A